- Home
- AUTL vs BHK Comparison
AUTL vs BHK Comparison
Compare AUTL & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- BHK
- Stock Information
- Founded
- AUTL 2014
- BHK 2001
- Country
- AUTL United Kingdom
- BHK United States
- Employees
- AUTL N/A
- BHK N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- BHK Finance Companies
- Sector
- AUTL Health Care
- BHK Finance
- Exchange
- AUTL Nasdaq
- BHK Nasdaq
- Market Cap
- AUTL 625.4M
- BHK 551.8M
- IPO Year
- AUTL 2018
- BHK N/A
- Fundamental
- Price
- AUTL $2.41
- BHK $9.85
- Analyst Decision
- AUTL Strong Buy
- BHK
- Analyst Count
- AUTL 5
- BHK 0
- Target Price
- AUTL $9.32
- BHK N/A
- AVG Volume (30 Days)
- AUTL 2.1M
- BHK 188.3K
- Earning Date
- AUTL 08-07-2025
- BHK 01-01-0001
- Dividend Yield
- AUTL N/A
- BHK 8.34%
- EPS Growth
- AUTL N/A
- BHK N/A
- EPS
- AUTL N/A
- BHK 1.03
- Revenue
- AUTL $9,011,000.00
- BHK N/A
- Revenue This Year
- AUTL $461.76
- BHK N/A
- Revenue Next Year
- AUTL $112.66
- BHK N/A
- P/E Ratio
- AUTL N/A
- BHK $10.42
- Revenue Growth
- AUTL N/A
- BHK N/A
- 52 Week Low
- AUTL $1.11
- BHK $9.02
- 52 Week High
- AUTL $5.00
- BHK $11.09
- Technical
- Relative Strength Index (RSI)
- AUTL 70.63
- BHK 46.49
- Support Level
- AUTL $2.20
- BHK $9.63
- Resistance Level
- AUTL $2.44
- BHK $9.78
- Average True Range (ATR)
- AUTL 0.12
- BHK 0.09
- MACD
- AUTL -0.01
- BHK 0.03
- Stochastic Oscillator
- AUTL 84.95
- BHK 70.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.